 |
 |

Adequacy of Clinical Trials Questioned at IOM Meeting
Charles Marwick
JAMA. 2000;283:1411-1412.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
WashingtonPhysicians who are considering prescribing a new drug or device or recommending a surgical procedure depend for assurance of efficacy on the published results of high-quality clinical trials. Unfortunately, all too often the trials are inadequate, said Joel J. Nobel, MD, speaking at a workshop held last month by the Institute of Medicine (IOM) on medical device innovation. Nobel is president of ECRI, headquartered in Plymouth Meeting, Pa, a widely recognized, nonprofit health services research agency focusing on health care technologies and quality.
"Our glowing assertions about the academic peer research model are wrong . . ." said Nobel. "The journal articles emerging from academic medical centers simply will not support evidence-based medicine." They cannot be used to support decisions about what works, how well it works, and whether it is worth doing, he asserted.
POLICY GUIDELINES LACKING
In 1989, ECRI surveyed the quality of medical research . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|